Meprobamate 200 mg/1
Meprobamate · TABLET · Cipla USA Inc.
Meprobamate is a tablet containing meprobamate at 200 mg/1, taken oral. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- Meprobamate
- Generic Name
- Meprobamate
- NDC Code (Product)
69097-974- Manufacturer
- Cipla USA Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- ANDA040797
- Marketing Start
- 06/07/2021
Recall History
Watson Laboratories Inc
Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .
Watson Laboratories Inc
Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .
Frequently Asked Questions
What is Meprobamate used for?
Meprobamate contains Meprobamate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Meprobamate a controlled substance?
Yes, Meprobamate is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for Meprobamate?
The generic name for Meprobamate is Meprobamate. There are 2 other brand versions of Meprobamate.
What is the NDC code for Meprobamate 200 mg/1?
The NDC (National Drug Code) for Meprobamate 200 mg/1 is 69097-974, listed by Cipla USA Inc..